Literature DB >> 3977436

Amikacin concentrations in serum following intraoperative irrigation of the pleura and peritoneum.

C W Van Way, G Hasse.   

Abstract

Serum concentrations of amikacin following operative wound irrigation were studied in 17 patients having laporatomy and in eight patients having thoracotomy. Irrigation was done with 500 mg of amikacin in 200 ml of saline. The irrigant was reaspirated after 3 minutes. Measurement of amikacin in the irrigant allowed calculation of the retained dose. Serum levels were measured before surgery, and at 30 minutes, 60 minutes, 6 hours, and 12 hours following irrigation. Amikacin was assayed by a microbiological technique. The retained dose after peritoneal irrigation was 350 +/- 128 mg, and after pleural irrigation was 100 +/- 79 mg. The average maximum serum level in the peritoneal irrigation group was 9.4 +/- 6.7 gm/ml; in the thoracotomy group it was 3.5 +/- 1.7. Fourteen of the 17 laparotomy patients but only one of the eight thoracotomy patients had measurable plasma levels at 6 hours. Plasma half-life in the laparotomy group was 2.81 +/- 1.34 hours, and in the thoracotomy group 1.53 +/- 0.83 hours. Interoperative amikacin irrigation, even with immediate aspiration, results in significant absorption in both thoracotomy and laporatomy patients. There was less absorption and a shorter serum half-life in the thoracotomy patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977436      PMCID: PMC1250675          DOI: 10.1097/00000658-198503000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

1.  INTRAPERITONEAL KANAMYCIN-- CLINICAL EXPERIENCE.

Authors:  I COHN; A M COTLAR; L RICHARD
Journal:  Am Surg       Date:  1963-11       Impact factor: 0.688

2.  THE ANTAGONISM OF CALCIUM AND NEOSTIGMINE TO KANAMYCIN-INDUCED NEUROMUSCULAR PARALYSIS.

Authors:  J G NAIMAN; K SAKURAI; J D MARTIN
Journal:  J Surg Res       Date:  1965-07       Impact factor: 2.192

3.  Intraperitoneal kanamycin.

Authors:  I COHN; A M COTLAR
Journal:  Ann Surg       Date:  1962-04       Impact factor: 12.969

4.  Intraperitoneal lavage and kanamycin for the contaminated abdomen.

Authors:  J L Nelson; J H Kuzman; I Cohn
Journal:  Surg Clin North Am       Date:  1975-12       Impact factor: 2.741

5.  The neuromuscular blocking action of gentamicin.

Authors:  O Vital Brazil; J Prado-Franceschi
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-05

6.  Absorption and excretion of intraperitoneally administered kanamycin sulfate.

Authors:  C A Pissiotis; R L Nichols; R E Condon
Journal:  Surg Gynecol Obstet       Date:  1972-06

7.  Respiratory insufficiency after intraperitoneal administration of Kanamycin: failure of calcium gluconate to reverse toxic effects.

Authors:  R C Noble
Journal:  South Med J       Date:  1976-09       Impact factor: 0.954

8.  Amikacin concentrations in uninfected postthoracotomy pleural fluid and in serum after intravenous and intrapleural injection.

Authors:  J P Thys; E Serruys-Schoutens; P Rocmans; A Herchuelz; M P Vanderlinden; E Yourassowsky
Journal:  Chest       Date:  1984-04       Impact factor: 9.410

9.  Clinical pharmacology of intravenous and intraperitoneal aminoglycoside antibiotics in the prevention of wound infections.

Authors:  C D Ericsson; J H Duke; L K Pickering
Journal:  Ann Surg       Date:  1978-07       Impact factor: 12.969

10.  The necessity of increased doses of amikacin in burn patients.

Authors:  D E Zaske; R J Sawchuk; R G Strate
Journal:  Surgery       Date:  1978-11       Impact factor: 3.982

  10 in total
  1 in total

1.  Competitive antagonism of fluorescent gentamicin uptake in the cochlea.

Authors:  Qi Wang; Allan Kachelmeier; P S Steyger
Journal:  Hear Res       Date:  2010-06-16       Impact factor: 3.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.